The global demand for COVID-19 Diagnostic Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
COVID-19 is the infectious disease caused by the most recently discovered SARS-2 coronavirus. This new virus was first detected in Wuhan, China, in December 2019. Many in-house and commercial assays that detect the COVID-19 virus are under development. Currently, two kinds of tests are available for COVID-19: viral tests and antibody tests. Diagnostic testing for COVID-19 tracks the virus, understanding epidemiology, informing case management, and to suppressing transmission. Techniques widely used for virus detection are PCR and nucleotide sequencing. There are variations in how diagnostics is being done across countries.
COVID-19 is a rapidly evolving situation, affecting many countries globally. COVID-19 diagnostic will continue to scale up to meet the growing demand in the local and national markets. Diagnostic testing is critical to stop the spread of COVID-19. There is a growing need to test a large number of patients to distinguish virus-infected patients from healthy. Looking at exponentially growing demand, manufacturers are ramping up testing and diagnostic capacity. Scientists across the world are developing new tests methodology to detect the virus. The factors contributing to the development of the new diagnostic process is an insufficiency of the currently available test to detect the virus, difficulty in executing a test, high cost of diagnostics, and more time consumption. However, in many countries diagnosis of COVID-19 is not yet regulated due to lack of knowledge and short of diagnostics kits which are limiting the growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of COVID-19 diagnostic.
The entire COVID-19 diagnostic market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Molecular Tests
- Serology Tests
- Public Health Labs
- Private or Commercial Labs
- Physician Labs
This section covers regional segmentation which accentuates on current and future demand for COVID-19 diagnostic market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global COVID-19 Diagnostic Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the COVID-19 diagnostic market include F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.